Cost advantage of voriconazole over amphotericin B deoxycholate for primary treatment of invasive aspergillosis

James S. Lewis, Helen W. Boucher, Teresa J. Lubowski, Ambarish J. Ambegaonkar, David L. Day, Thomas F. Patterson

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Cost advantage of voriconazole over amphotericin B deoxycholate for primary treatment of invasive aspergillosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science